BridgeBio Pharma Reports Month 12 Topline Results from Phase 3 ATTRibute-CM Study

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

,Bio Pharma ,Neil Kumar ,Katherine Yau ,Linkedin ,York Heart Association ,Twitter ,Steering Committee ,Division Of Cardiology ,Nasdaq ,Bridgebio Pharma Inc ,University Of South Carolina ,Securities Exchange ,Bio Pharma Inc ,Daniel Judge ,Medical University ,South Carolina ,New York Heart Association ,Transthyretin Amyloidosis ,Bridgebio Pharma ,Forward Looking Statements ,Securities Act ,Securities Exchange Act ,Exchange Act ,Risk Factors ,Annual Report ,Bio Media Contact ,Bio Investor Contact ,Business ,Health ,Globe Newswire ,